Kwang-Seok Park

Leonard Green & Partners LP (Leonard Green & Partners) is a private equity firm founded in 1989 by Leonard I. Green. The firm is headquartered in Los Angeles, California.

Samsung Venture Investment Corp. (SVIC) is a corporate venture capital investment firm based in Seoul, South Korea. Founded in 1999, they manage investment and investment-related activities for the Samsung Group. The parent firm, founded in 1938 and headquartered in Seoul, produces semiconductors, business communications systems, reciprocating and rotary compressors, optical and hard disc drives, LCD panels, set-top boxes, CC televisions, as well as fiber optics. In 2004, SVIC established Samsung Ventures America, their US-based venture capital arm.

SBVA (SBVA) is a private equity/venture capital subsidiary of SoftBank Korea Co., Ltd founded in 2000. The firm is headquartered in Seoul, South Korea.

True Capital Partners LLP (True Capital Partners) is a private equity and venture capital firm founded in 2012 by Paul Andrew Cocker and Matthew A. Truman. The firm is headquartered in London, the United Kingdom.

Paratus Investment, Inc. (Paratus Invest) is an independent private equity and venture capital firm headquartered in Seoul, Korea. The firm is established in 2014.

Digital Healthcare Partners, Inc. (DHP) is an accelerator firm founded in 2016 by Yun-seob Choi. The firm is headquartered in Seoul, South Korea.

3billion, Inc. is a biotechnology company. The firm provides genetic screening directly to rare disease patients. The company was founded by Chang-Won Keum in 2016 and is headquartered in Seoul, South Korea.

Hashed Co. Ltd. (Hashed) is an accelerator & incubator firm founded in 2018. The firm is headquartered in Seoul, South Korea with an office in San Francisco.

i-sense is an interdisciplinary research collaboration that aims to develop new digital tools and technologies to track, test, and treat infectious diseases. The British company supports initiatives that promote engagement and forward-thinking between academics, patients, clinicians, industry, regulators, policy makers, and the media. i-sense started in 2013 as a five-year, £11M IRC funded by the Engineering and Physical Sciences Research Council. The non-profit company received Next Steps funding from the same council for a further four years of research. The company's researchers are working to harness the power of mobile phones, biomedical engineering, nanotechnology, genomics, and big data to detect diseases much earlier than ever before.

Encell Co. Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It provides customized pharmaceutical development services, from early development stage to approval stage. The company was founded in February 2018 and is headquartered in Gangnam-gu, Seoul.